Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Rite Aid Corporation (NYSE:RAD) Share Price

Press coverage about Rite Aid Corporation (NYSE:RAD) has been trending somewhat positive this week, Accern reports. Accern identifies negative and positive press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Rite Aid Corporation earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.0086210131388 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the media stories that may have effected Accern Sentiment’s scoring:

Shares of Rite Aid Corporation (RAD) opened at 2.22 on Friday. Rite Aid Corporation has a one year low of $2.21 and a one year high of $8.77. The stock’s market capitalization is $2.32 billion. The stock’s 50 day moving average is $2.39 and its 200-day moving average is $3.88.

Rite Aid Corporation (NYSE:RAD) last announced its earnings results on Thursday, June 29th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.04. The firm had revenue of $7.78 billion during the quarter, compared to analysts’ expectations of $8.29 billion. Rite Aid Corporation had a negative net margin of 0.21% and a positive return on equity of 0.52%. Rite Aid Corporation’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.02 earnings per share. On average, equities research analysts predict that Rite Aid Corporation will post ($0.09) EPS for the current fiscal year.

RAD has been the topic of a number of recent analyst reports. Zacks Investment Research raised Rite Aid Corporation from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 16th. Cowen and Company reaffirmed an “outperform” rating and set a $4.70 price target on shares of Rite Aid Corporation in a research report on Monday, July 3rd. Mizuho downgraded Rite Aid Corporation from a “buy” rating to a “neutral” rating and set a $2.95 price target on the stock. in a research report on Thursday, July 20th. Guggenheim reaffirmed a “neutral” rating on shares of Rite Aid Corporation in a research report on Monday, July 3rd. Finally, Bank of America Corporation reaffirmed an “underperform” rating and set a $2.00 price target on shares of Rite Aid Corporation in a research report on Friday, June 30th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $4.53.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by BNB Daily and is owned by of BNB Daily. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at

Rite Aid Corporation Company Profile

Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.

Insider Buying and Selling by Quarter for Rite Aid Corporation (NYSE:RAD)

Receive News & Ratings for Rite Aid Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid Corporation and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply